APO Research
Talk to an analyst

APO RESEARCH · REPORT

Heparin Sodium Injection

Compare research editions
View pricing & licenses

Selected research

Industry Research

Heparin Sodium Injection Industry Research Report 2026

22 December 2025132 pages

Choose your research edition.

Industry ResearchHeparin Sodium Injection Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Heparin Sodium Injection Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Heparin Sodium Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Heparin Sodium Injection Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Heparin Sodium Injection Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Heparin Sodium Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Heparin Sodium Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Heparin Sodium Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Heparin Sodium Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Heparin Sodium Injection include Sichuan Deebio, Shenzhen Hepalink, Nanjing King-friend, Pfizer, Changzhou Qianhong Bio-pharma, Baxter, Yino Pharma Limited, Xinbai Pharmaceuticals and Pharma Action, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Heparin Sodium Injection market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Heparin Sodium Injection Market by Company

Sichuan Deebio

Shenzhen Hepalink

Nanjing King-friend

Pfizer

Changzhou Qianhong Bio-pharma

Baxter

Yino Pharma Limited

Xinbai Pharmaceuticals

Pharma Action

Opocrin

Dongying Tiandong Pharmaceutical

Dongcheng Biochemicals

Changshan Biochemical

Bioibérica

Aspen Oss

Heparin Sodium Injection Segment by Type

1, 000 USP Units / mL

5, 000 USP Units / mL

10, 000 USP Units / mL

Heparin Sodium Injection Segment by Application

Cardioversion of Atrial Fibrillation/Flutter

Complications of Pregnancy

Treatment of Venous Thromboembolism

Other

Heparin Sodium Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Heparin Sodium Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Heparin Sodium Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Heparin Sodium Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Heparin Sodium Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Heparin Sodium Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Heparin Sodium Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Heparin Sodium Injection Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Heparin Sodium Injection Sales (k units) of Manufacturers (2021-2026) Table 7. Global Heparin Sodium Injection Sales Market Share by Manufacturers (2021-2026) Table 8. Global Heparin Sodium Injection Revenue of Manufacturers (2021-2026) Table 9. Global Heparin Sodium Injection Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Heparin Sodium Injection Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Heparin Sodium Injection Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Heparin Sodium Injection, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Heparin Sodium Injection, Product Type & Application Table 14. Global Heparin Sodium Injection Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Heparin Sodium Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Sichuan Deebio Company Information Table 19. Sichuan Deebio Business Overview Table 20. Sichuan Deebio Heparin Sodium Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Sichuan Deebio Heparin Sodium Injection Product Portfolio Table 22. Sichuan Deebio Recent Developments Table 23. Shenzhen Hepalink Company Information Table 24. Shenzhen Hepalink Business Overview Table 25. Shenzhen Hepalink Heparin Sodium Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Shenzhen Hepalink Heparin Sodium Injection Product Portfolio Table 27. Shenzhen Hepalink Recent Developments Table 28. Nanjing King-friend Company Information Table 29. Nanjing King-friend Business Overview Table 30. Nanjing King-friend Heparin Sodium Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Nanjing King-friend Heparin Sodium Injection Product Portfolio Table 32. Nanjing King-friend Recent Developments Table 33. Pfizer Company Information Table 34. Pfizer Business Overview Table 35. Pfizer Heparin Sodium Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Pfizer Heparin Sodium Injection Product Portfolio Table 37. Pfizer Recent Developments Table 38. Changzhou Qianhong Bio-pharma Company Information Table 39. Changzhou Qianhong Bio-pharma Business Overview Table 40. Changzhou Qianhong Bio-pharma Heparin Sodium Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Changzhou Qianhong Bio-pharma Heparin Sodium Injection Product Portfolio Table 42. Changzhou Qianhong Bio-pharma Recent Developments Table 43. Baxter Company Information Table 44. Baxter Business Overview Table 45. Baxter Heparin Sodium Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Baxter Heparin Sodium Injection Product Portfolio Table 47. Baxter Recent Developments Table 48. Yino Pharma Limited Company Information Table 49. Yino Pharma Limited Business Overview Table 50. Yino Pharma Limited Heparin Sodium Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Yino Pharma Limited Heparin Sodium Injection Product Portfolio Table 52. Yino Pharma Limited Recent Developments Table 53. Xinbai Pharmaceuticals Company Information Table 54. Xinbai Pharmaceuticals Business Overview Table 55. Xinbai Pharmaceuticals Heparin Sodium Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. Xinbai Pharmaceuticals Heparin Sodium Injection Product Portfolio Table 57. Xinbai Pharmaceuticals Recent Developments Table 58. Pharma Action Company Information Table 59. Pharma Action Business Overview Table 60. Pharma Action Heparin Sodium Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Pharma Action Heparin Sodium Injection Product Portfolio Table 62. Pharma Action Recent Developments Table 63. Opocrin Company Information Table 64. Opocrin Business Overview Table 65. Opocrin Heparin Sodium Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Opocrin Heparin Sodium Injection Product Portfolio Table 67. Opocrin Recent Developments Table 68. Dongying Tiandong Pharmaceutical Company Information Table 69. Dongying Tiandong Pharmaceutical Business Overview Table 70. Dongying Tiandong Pharmaceutical Heparin Sodium Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Dongying Tiandong Pharmaceutical Heparin Sodium Injection Product Portfolio Table 72. Dongying Tiandong Pharmaceutical Recent Developments Table 73. Dongcheng Biochemicals Company Information Table 74. Dongcheng Biochemicals Business Overview Table 75. Dongcheng Biochemicals Heparin Sodium Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Dongcheng Biochemicals Heparin Sodium Injection Product Portfolio Table 77. Dongcheng Biochemicals Recent Developments Table 78. Changshan Biochemical Company Information Table 79. Changshan Biochemical Business Overview Table 80. Changshan Biochemical Heparin Sodium Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Changshan Biochemical Heparin Sodium Injection Product Portfolio Table 82. Changshan Biochemical Recent Developments Table 83. Bioibérica Company Information Table 84. Bioibérica Business Overview Table 85. Bioibérica Heparin Sodium Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Bioibérica Heparin Sodium Injection Product Portfolio Table 87. Bioibérica Recent Developments Table 88. Aspen Oss Company Information Table 89. Aspen Oss Business Overview Table 90. Aspen Oss Heparin Sodium Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Aspen Oss Heparin Sodium Injection Product Portfolio Table 92. Aspen Oss Recent Developments Table 93. Global Heparin Sodium Injection Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 94. Global Heparin Sodium Injection Sales by Region (2021-2026) & (k units) Table 95. Global Heparin Sodium Injection Sales Market Share by Region (2021-2026) Table 96. Global Heparin Sodium Injection Sales by Region (2027-2032) & (k units) Table 97. Global Heparin Sodium Injection Sales Market Share by Region (2027-2032) Table 98. Global Heparin Sodium Injection Revenue by Region (2021-2026) & (US$ Million) Table 99. Global Heparin Sodium Injection Revenue Market Share by Region (2021-2026) Table 100. Global Heparin Sodium Injection Revenue by Region (2027-2032) & (US$ Million) Table 101. Global Heparin Sodium Injection Revenue Market Share by Region (2027-2032) Table 102. North America Heparin Sodium Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. North America Heparin Sodium Injection Sales by Country (2021-2026) & (k units) Table 104. North America Heparin Sodium Injection Sales by Country (2027-2032) & (k units) Table 105. North America Heparin Sodium Injection Revenue by Country (2021-2026) & (US$ Million) Table 106. North America Heparin Sodium Injection Revenue by Country (2027-2032) & (US$ Million) Table 107. Europe Heparin Sodium Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Europe Heparin Sodium Injection Sales by Country (2021-2026) & (k units) Table 109. Europe Heparin Sodium Injection Sales by Country (2027-2032) & (k units) Table 110. Europe Heparin Sodium Injection Revenue by Country (2021-2026) & (US$ Million) Table 111. Europe Heparin Sodium Injection Revenue by Country (2027-2032) & (US$ Million) Table 112. Asia Pacific Heparin Sodium Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Asia Pacific Heparin Sodium Injection Sales by Country (2021-2026) & (k units) Table 114. Asia Pacific Heparin Sodium Injection Sales by Country (2027-2032) & (k units) Table 115. Asia Pacific Heparin Sodium Injection Revenue by Country (2021-2026) & (US$ Million) Table 116. Asia Pacific Heparin Sodium Injection Revenue by Country (2027-2032) & (US$ Million) Table 117. South America Heparin Sodium Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. South America Heparin Sodium Injection Sales by Country (2021-2026) & (k units) Table 119. South America Heparin Sodium Injection Sales by Country (2027-2032) & (k units) Table 120. South America Heparin Sodium Injection Revenue by Country (2021-2026) & (US$ Million) Table 121. South America Heparin Sodium Injection Revenue by Country (2027-2032) & (US$ Million) Table 122. Middle East and Africa Heparin Sodium Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Middle East and Africa Heparin Sodium Injection Sales by Country (2021-2026) & (k units) Table 124. Middle East and Africa Heparin Sodium Injection Sales by Country (2027-2032) & (k units) Table 125. Middle East and Africa Heparin Sodium Injection Revenue by Country (2021-2026) & (US$ Million) Table 126. Middle East and Africa Heparin Sodium Injection Revenue by Country (2027-2032) & (US$ Million) Table 127. Global Heparin Sodium Injection Sales by Type (2021-2026) & (k units) Table 128. Global Heparin Sodium Injection Sales by Type (2027-2032) & (k units) Table 129. Global Heparin Sodium Injection Sales Market Share by Type (2021-2026) Table 130. Global Heparin Sodium Injection Sales Market Share by Type (2027-2032) Table 131. Global Heparin Sodium Injection Revenue by Type (2021-2026) & (US$ Million) Table 132. Global Heparin Sodium Injection Revenue by Type (2027-2032) & (US$ Million) Table 133. Global Heparin Sodium Injection Revenue Market Share by Type (2021-2026) Table 134. Global Heparin Sodium Injection Revenue Market Share by Type (2027-2032) Table 135. Global Heparin Sodium Injection Price by Type (2021-2026) & (US$/unit) Table 136. Global Heparin Sodium Injection Price by Type (2027-2032) & (US$/unit) Table 137. Global Heparin Sodium Injection Sales by Application (2021-2026) & (k units) Table 138. Global Heparin Sodium Injection Sales by Application (2027-2032) & (k units) Table 139. Global Heparin Sodium Injection Sales Market Share by Application (2021-2026) Table 140. Global Heparin Sodium Injection Sales Market Share by Application (2027-2032) Table 141. Global Heparin Sodium Injection Revenue by Application (2021-2026) & (US$ Million) Table 142. Global Heparin Sodium Injection Revenue by Application (2027-2032) & (US$ Million) Table 143. Global Heparin Sodium Injection Revenue Market Share by Application (2021-2026) Table 144. Global Heparin Sodium Injection Revenue Market Share by Application (2027-2032) Table 145. Global Heparin Sodium Injection Price by Application (2021-2026) & (US$/unit) Table 146. Global Heparin Sodium Injection Price by Application (2027-2032) & (US$/unit) Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Heparin Sodium Injection Distributors List Table 150. Heparin Sodium Injection Customers List Table 151. Heparin Sodium Injection Industry Trends Table 152. Heparin Sodium Injection Industry Drivers Table 153. Heparin Sodium Injection Industry Restraints Table 154. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Heparin Sodium Injection Product Image Figure 5. Global Heparin Sodium Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Heparin Sodium Injection Market Size (2021-2032) & (US$ Million) Figure 7. Global Heparin Sodium Injection Sales (2021-2032) & (k units) Figure 8. Global Heparin Sodium Injection Average Price (US$/unit) & (2021-2032) Figure 9. 1, 000 USP Units / mL Product Image Figure 10. 5, 000 USP Units / mL Product Image Figure 11. 10, 000 USP Units / mL Product Image Figure 12. Cardioversion of Atrial Fibrillation/Flutter Product Image Figure 13. Complications of Pregnancy Product Image Figure 14. Treatment of Venous Thromboembolism Product Image Figure 15. Other Product Image Figure 16. Global Heparin Sodium Injection Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Heparin Sodium Injection, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Heparin Sodium Injection Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Heparin Sodium Injection Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Heparin Sodium Injection Sales by Region in 2025 Figure 22. Global Heparin Sodium Injection Revenue by Region in 2025 Figure 23. North America Heparin Sodium Injection Market Size by Country in 2025 Figure 24. North America Heparin Sodium Injection Sales Market Share by Country (2021-2032) Figure 25. North America Heparin Sodium Injection Revenue Market Share by Country (2021-2032) Figure 26. United States Heparin Sodium Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Heparin Sodium Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico Heparin Sodium Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Heparin Sodium Injection Market Size by Country in 2025 Figure 30. Europe Heparin Sodium Injection Sales Market Share by Country (2021-2032) Figure 31. Europe Heparin Sodium Injection Revenue Market Share by Country (2021-2032) Figure 32. Germany Heparin Sodium Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Heparin Sodium Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Heparin Sodium Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Heparin Sodium Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia Heparin Sodium Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain Heparin Sodium Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Heparin Sodium Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland Heparin Sodium Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden Heparin Sodium Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland Heparin Sodium Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Heparin Sodium Injection Market Size by Country in 2025 Figure 43. Asia Pacific Heparin Sodium Injection Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Heparin Sodium Injection Revenue Market Share by Country (2021-2032) Figure 45. China Heparin Sodium Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Heparin Sodium Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Heparin Sodium Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Heparin Sodium Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Heparin Sodium Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan Heparin Sodium Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Heparin Sodium Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Heparin Sodium Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Heparin Sodium Injection Market Size by Country in 2025 Figure 54. South America Heparin Sodium Injection Sales Market Share by Country (2021-2032) Figure 55. South America Heparin Sodium Injection Revenue Market Share by Country (2021-2032) Figure 56. Brazil Heparin Sodium Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Heparin Sodium Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile Heparin Sodium Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Heparin Sodium Injection Market Size by Country in 2025 Figure 60. Middle East and Africa Heparin Sodium Injection Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Heparin Sodium Injection Revenue Market Share by Country (2021-2032) Figure 62. Egypt Heparin Sodium Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Heparin Sodium Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Heparin Sodium Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Heparin Sodium Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Heparin Sodium Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Heparin Sodium Injection Sales Market Share by Type (2021-2032) Figure 68. Global Heparin Sodium Injection Revenue Market Share by Type (2021-2032) Figure 69. Global Heparin Sodium Injection Price (US$/unit) by Type (2021-2032) Figure 70. Global Heparin Sodium Injection Sales Market Share by Application (2021-2032) Figure 71. Global Heparin Sodium Injection Revenue Market Share by Application (2021-2032) Figure 72. Global Heparin Sodium Injection Price (US$/unit) by Application (2021-2032) Figure 73. Heparin Sodium Injection Value Chain Figure 74. Heparin Sodium Injection Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Heparin Sodium Injection Industry Opportunities and Challenges

Scope & coverage.

Types
  • 1, 000 USP Units / mL
  • 5, 000 USP Units / mL
  • 10, 000 USP Units / mL
Applications
  • Cardioversion of Atrial Fibrillation/Flutter
  • Complications of Pregnancy
  • Treatment of Venous Thromboembolism
  • Other
Companies covered
  • Sichuan Deebio
  • Shenzhen Hepalink
  • Nanjing King-friend
  • Pfizer
  • Changzhou Qianhong Bio-pharma
  • Baxter
  • Yino Pharma Limited
  • Xinbai Pharmaceuticals
  • Pharma Action
  • Opocrin
  • Dongying Tiandong Pharmaceutical
  • Dongcheng Biochemicals
  • Changshan Biochemical
  • Bioibérica
  • Aspen Oss

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Heparin Sodium Injection Market Size (2021-2032)
  4. 2.2.2 Global Heparin Sodium Injection Sales (2021-2032)
  5. 2.2.3 Global Heparin Sodium Injection Market Average Price (2021-2032)
  6. 2.3 Heparin Sodium Injection by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 1, 000 USP Units / mL
  9. 2.3.3 5, 000 USP Units / mL
  10. 2.3.4 10, 000 USP Units / mL
  11. 2.4 Heparin Sodium Injection by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Cardioversion of Atrial Fibrillation/Flutter
  14. 2.4.3 Complications of Pregnancy
  15. 2.4.4 Treatment of Venous Thromboembolism
  16. 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Heparin Sodium Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Heparin Sodium Injection Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Heparin Sodium Injection Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Heparin Sodium Injection Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Heparin Sodium Injection Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Heparin Sodium Injection, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Heparin Sodium Injection, Product Type & Application
  8. 3.8 Global Manufacturers of Heparin Sodium Injection, Established Date
  9. 3.9 Global Heparin Sodium Injection Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Sichuan Deebio
  2. 4.1.1 Sichuan Deebio Company Information
  3. 4.1.2 Sichuan Deebio Business Overview
  4. 4.1.3 Sichuan Deebio Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Sichuan Deebio Heparin Sodium Injection Product Portfolio
  6. 4.1.5 Sichuan Deebio Recent Developments
  7. 4.2 Shenzhen Hepalink
  8. 4.2.1 Shenzhen Hepalink Company Information
  9. 4.2.2 Shenzhen Hepalink Business Overview
  10. 4.2.3 Shenzhen Hepalink Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Shenzhen Hepalink Heparin Sodium Injection Product Portfolio
  12. 4.2.5 Shenzhen Hepalink Recent Developments
  13. 4.3 Nanjing King-friend
  14. 4.3.1 Nanjing King-friend Company Information
  15. 4.3.2 Nanjing King-friend Business Overview
  16. 4.3.3 Nanjing King-friend Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Nanjing King-friend Heparin Sodium Injection Product Portfolio
  18. 4.3.5 Nanjing King-friend Recent Developments
  19. 4.4 Pfizer
  20. 4.4.1 Pfizer Company Information
  21. 4.4.2 Pfizer Business Overview
  22. 4.4.3 Pfizer Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Pfizer Heparin Sodium Injection Product Portfolio
  24. 4.4.5 Pfizer Recent Developments
  25. 4.5 Changzhou Qianhong Bio-pharma
  26. 4.5.1 Changzhou Qianhong Bio-pharma Company Information
  27. 4.5.2 Changzhou Qianhong Bio-pharma Business Overview
  28. 4.5.3 Changzhou Qianhong Bio-pharma Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Changzhou Qianhong Bio-pharma Heparin Sodium Injection Product Portfolio
  30. 4.5.5 Changzhou Qianhong Bio-pharma Recent Developments
  31. 4.6 Baxter
  32. 4.6.1 Baxter Company Information
  33. 4.6.2 Baxter Business Overview
  34. 4.6.3 Baxter Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Baxter Heparin Sodium Injection Product Portfolio
  36. 4.6.5 Baxter Recent Developments
  37. 4.7 Yino Pharma Limited
  38. 4.7.1 Yino Pharma Limited Company Information
  39. 4.7.2 Yino Pharma Limited Business Overview
  40. 4.7.3 Yino Pharma Limited Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Yino Pharma Limited Heparin Sodium Injection Product Portfolio
  42. 4.7.5 Yino Pharma Limited Recent Developments
  43. 4.8 Xinbai Pharmaceuticals
  44. 4.8.1 Xinbai Pharmaceuticals Company Information
  45. 4.8.2 Xinbai Pharmaceuticals Business Overview
  46. 4.8.3 Xinbai Pharmaceuticals Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Xinbai Pharmaceuticals Heparin Sodium Injection Product Portfolio
  48. 4.8.5 Xinbai Pharmaceuticals Recent Developments
  49. 4.9 Pharma Action
  50. 4.9.1 Pharma Action Company Information
  51. 4.9.2 Pharma Action Business Overview
  52. 4.9.3 Pharma Action Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Pharma Action Heparin Sodium Injection Product Portfolio
  54. 4.9.5 Pharma Action Recent Developments
  55. 4.10 Opocrin
  56. 4.10.1 Opocrin Company Information
  57. 4.10.2 Opocrin Business Overview
  58. 4.10.3 Opocrin Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Opocrin Heparin Sodium Injection Product Portfolio
  60. 4.10.5 Opocrin Recent Developments
  61. 4.11 Dongying Tiandong Pharmaceutical
  62. 4.11.1 Dongying Tiandong Pharmaceutical Company Information
  63. 4.11.2 Dongying Tiandong Pharmaceutical Business Overview
  64. 4.11.3 Dongying Tiandong Pharmaceutical Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Dongying Tiandong Pharmaceutical Heparin Sodium Injection Product Portfolio
  66. 4.11.5 Dongying Tiandong Pharmaceutical Recent Developments
  67. 4.12 Dongcheng Biochemicals
  68. 4.12.1 Dongcheng Biochemicals Company Information
  69. 4.12.2 Dongcheng Biochemicals Business Overview
  70. 4.12.3 Dongcheng Biochemicals Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Dongcheng Biochemicals Heparin Sodium Injection Product Portfolio
  72. 4.12.5 Dongcheng Biochemicals Recent Developments
  73. 4.13 Changshan Biochemical
  74. 4.13.1 Changshan Biochemical Company Information
  75. 4.13.2 Changshan Biochemical Business Overview
  76. 4.13.3 Changshan Biochemical Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Changshan Biochemical Heparin Sodium Injection Product Portfolio
  78. 4.13.5 Changshan Biochemical Recent Developments
  79. 4.14 Bioibérica
  80. 4.14.1 Bioibérica Company Information
  81. 4.14.2 Bioibérica Business Overview
  82. 4.14.3 Bioibérica Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Bioibérica Heparin Sodium Injection Product Portfolio
  84. 4.14.5 Bioibérica Recent Developments
  85. 4.15 Aspen Oss
  86. 4.15.1 Aspen Oss Company Information
  87. 4.15.2 Aspen Oss Business Overview
  88. 4.15.3 Aspen Oss Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Aspen Oss Heparin Sodium Injection Product Portfolio
  90. 4.15.5 Aspen Oss Recent Developments
5 Global Heparin Sodium Injection Market Scenario by Region
  1. 5.1 Global Heparin Sodium Injection Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Heparin Sodium Injection Sales by Region: 2021-2032
  3. 5.2.1 Global Heparin Sodium Injection Sales by Region: 2021-2026
  4. 5.2.2 Global Heparin Sodium Injection Sales by Region: 2027-2032
  5. 5.3 Global Heparin Sodium Injection Revenue by Region: 2021-2032
  6. 5.3.1 Global Heparin Sodium Injection Revenue by Region: 2021-2026
  7. 5.3.2 Global Heparin Sodium Injection Revenue by Region: 2027-2032
  8. 5.4 North America Heparin Sodium Injection Market Facts & Figures by Country
  9. 5.4.1 North America Heparin Sodium Injection Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Heparin Sodium Injection Sales by Country (2021-2032)
  11. 5.4.3 North America Heparin Sodium Injection Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Heparin Sodium Injection Market Facts & Figures by Country
  16. 5.5.1 Europe Heparin Sodium Injection Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Heparin Sodium Injection Sales by Country (2021-2032)
  18. 5.5.3 Europe Heparin Sodium Injection Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Heparin Sodium Injection Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Heparin Sodium Injection Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Heparin Sodium Injection Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Heparin Sodium Injection Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Heparin Sodium Injection Market Facts & Figures by Country
  41. 5.7.1 South America Heparin Sodium Injection Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Heparin Sodium Injection Sales by Country (2021-2032)
  43. 5.7.3 South America Heparin Sodium Injection Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Heparin Sodium Injection Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Heparin Sodium Injection Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Heparin Sodium Injection Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Heparin Sodium Injection Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Heparin Sodium Injection Sales by Type (2021-2032)
  2. 6.1.1 Global Heparin Sodium Injection Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Heparin Sodium Injection Sales Market Share by Type (2021-2032)
  4. 6.2 Global Heparin Sodium Injection Revenue by Type (2021-2032)
  5. 6.2.1 Global Heparin Sodium Injection Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Heparin Sodium Injection Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Heparin Sodium Injection Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Heparin Sodium Injection Sales by Application (2021-2032)
  2. 7.1.1 Global Heparin Sodium Injection Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Heparin Sodium Injection Sales Market Share by Application (2021-2032)
  4. 7.2 Global Heparin Sodium Injection Revenue by Application (2021-2032)
  5. 7.2.1 Global Heparin Sodium Injection Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Heparin Sodium Injection Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Heparin Sodium Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Heparin Sodium Injection Value Chain Analysis
  2. 8.1.1 Heparin Sodium Injection Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Heparin Sodium Injection Production Mode & Process
  5. 8.2 Heparin Sodium Injection Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Heparin Sodium Injection Distributors
  8. 8.2.3 Heparin Sodium Injection Customers
9 Global Heparin Sodium Injection Analyzing Market Dynamics
  1. 9.1 Heparin Sodium Injection Industry Trends
  2. 9.2 Heparin Sodium Injection Industry Drivers
  3. 9.3 Heparin Sodium Injection Industry Opportunities and Challenges
  4. 9.4 Heparin Sodium Injection Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst